Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia.

Gynecologic oncology·2023
Same author

Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia.

Gynecologic oncology·2022
Same author

PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?

International journal of cancer·2022
Same author

Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia.

British journal of cancer·2020
Same author

M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.

International journal of cancer·2020
Same author

Placental site trophoblastic tumour and epithelioid trophoblastic tumour.

Best practice & research. Clinical obstetrics & gynaecology·2020

関連する実験動画

Updated: Jul 13, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

ノン・ホジキンリンパ腫 (NHL) とは

Linda S Evans1, Barry W Hancock

  • 1Weston Park Hospital, S10 2SJ, Sheffield, UK.

Lancet (London, England)
|July 18, 2003
PubMed
まとめ

ノンホッジキン型リンパ腫は,様々な悪性疾患を含む. 分子生物学,分類,化学療法やモノクローナル抗体などの治療法の進歩は,成人リンパ腫の予後を改善しています.

科学分野:

  • 腫瘍学 腫瘍学
  • 血液学 ヘマトロジ
  • 分子生物学は分子生物学である.

背景:

  • ノン-ホッジキンリンパ腫は,様々な臨床的および組織学的特徴を持つリンパ増殖性悪性疾患の広範な用語です.
  • 診断は困難であり,約25%の症例が外ノダルで発症し,ユニークな臨床問題を引き起こします.

研究 の 目的:

  • 大人のリンパ腫の分子基盤を探求するためです.
  • 生物学的理解に基づく分類システムの開発について議論する.
  • 洗練された予後因子グループが臨床管理にどのように役立つかを検討する.

主な方法:

  • リンパ腫サブタイプの分子基盤のレビュー.
  • 進化する分類システムの分析.
  • 臨床的意思決定における予後要因の評価.

主要な成果:

  • 分子基盤を理解することで,リンパ腫のサブグループの分類が改善されました.
  • 洗練された予後要因の識別は,臨床管理戦略を強化します.
  • 化学療法は,攻撃的なリンパ腫の生存率を向上させました; 新種の治療法は,怠惰なタイプと攻撃的なタイプに希望を示しています.

さらに関連する動画

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

関連する実験動画

Last Updated: Jul 13, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

結論:

  • 生物学的な分類システムは,成人のリンパ腫の管理に不可欠です.
  • 化学療法とモノクローナル抗体療法の進歩は,患者のアウトカムを改善しています.
  • 分子メカニズムと新しい治療法に関する継続的な研究は,リンパ腫の予後をさらに改善します.